Variant Bio, a genomics-driven AI drug discovery company, today announced the launch of Inference, the world's first agentic genomic drug dis ...
Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic ...
After raising $33 million in just 15 seconds, Shivom has entered into partnership with SingularityNet, in order to combine blockchain, AI and genomic research in order to achieve advanced, ...
The Mystra platform, developed over 10 years, offers biopharma partners proven analytical power to turn months of R&D into minutes, dramatically increasing the availability of quality genetic insights ...
LAKE FOREST, Calif.--(BUSINESS WIRE)--Genomic Testing Cooperative (GTC), a leader in advanced genomic testing, announced the launch of GTC Interpret, a new web-based platform designed to provide Co-Op ...
Transaction combines Sema4’s leading AI- and machine learning-powered integrated genomic and clinical open-architecture data platform, with CM Life Sciences, the leading life science-focused SPAC, led ...
WuXi NextCODE closed a $240 million Series B financing round. Sequoia China led the funding round. WuXi NextCODE is a global platform for genomic data. It will use the funds to extend platform ...
eSpeaks’ Corey Noles talks with Rob Israch, President of Tipalti, about what it means to lead with Global-First Finance and how companies can build scalable, compliant operations in an increasingly ...
In May 2024, CGP was incorporated into Taiwan’s National Health Insurance (NHI) program.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback